Browsing by Author "Nogueira, F"
Now showing 1 - 3 of 3
Results Per Page
Sort Options
- Deep infiltrating endometriosis of the colon causing cyclic bleedingPublication . Ribeiro, C; Nogueira, F; Guerreiro, SC; Leão, P
- International consensus on natural orifice specimen extraction surgery (NOSES) for colorectal cancerPublication . Guan, X; Liu, Z; Longo, A; Cai, JC; Tzu-Liang Chen, W; Chen, L; Chun, HK; Costa Pereira, JM; Efetov, S; Escalante, R; He, QS; Hu, JH; Kayaalp, C; Kim, SH; Khan, JS; Kuo, LJ; Nishimura, A; Nogueira, F; Okuda, J; Saklani, A; Shafik, AA; Shen, MY; Son, JT; Song, JM; Sun, DH; Uehara, K; Wang, GY; Wei, Y; Xiong, ZG; Yao, HL; Yu, G; Yu, SJ; Zhou, HT; Lee, SH; Tsarkov, PV; Fu, Chuan-Gang; Wang, Xi-ShanIn recent years, natural orifice specimen extraction surgery (NOSES) in the treatment of colorectal cancer has attracted widespread attention. The potential benefits of NOSES including reduction in postoperative pain and wound complications, less use of postoperative analgesic, faster recovery of bowel function, shorter length of hospital stay, better cosmetic and psychological effect have been described in colorectal surgery. Despite significant decrease in surgical trauma of NOSES have been observed, the potential pitfalls of this technique have been demonstrated. Particularly, several issues including bacteriological concerns, oncological outcomes and patient selection are raised with this new technique. Therefore, it is urgent and necessary to reach a consensus as an industry guideline to standardize the implementation of NOSES in colorectal surgery. After three rounds of discussion by all members of the International Alliance of NOSES, the consensus is finally completed, which is also of great significance to the long-term progress of NOSES worldwide.
- The influence of metabolic syndrome in the outcomes of colorectal cancer patientsPublication . Goulart, A; Varejão, A; Nogueira, F; Martins, S; Mesquita-Rodrigues, A; Sousa, N; Leão, PAIMS: Determine the influence of metabolic syndrome and its different components in the outcomes of colorectal cancer surgery at 30days. MATERIALS AND METHODS: Prospective study that included all patients submitted to elective colorectal cancer surgery between August 2015 and August 2016 at Hospital de Braga. Clinical and laboratory parameters evaluated pre-operatively were: central obesity, blood pressure, fasting glucose, triglycerides levels and HDL cholesterol levels. Any complications during the first 30-days after surgery were recorded (readmission, reintervention, anastomotic dehiscence, morbimortality). RESULTS: One hundred and thirty-four patients were included. Metabolic syndrome was diagnostic in 40.7% of patients with the ATPIII definition, 67.5% with the AHA definition and 67.0% with the IDF definition. At 30days after colorectal cancer surgery, 73.1% patients don't have any complication, 15.7% have minor complications (grade I/II of Clavien-Dindo classification), 11.1% have major complications (grade III/IV/V of Clavien-Dindo classification) and 1.5% have died from surgical complications (grade V of Clavien-Dindo classification). The statistic analysis didn't reveal any association between MS, or it's different components, and surgical outcomes. CONCLUSION: This study seems to indicate that metabolic syndrome don't have any influence in surgical outcomes of colorectal cancer surgery.